Established and experimental medical therapy of pulmonary sarcoidosis
Authors:
- Robert P. BaughmanRBRobert P. Baughman
- Hilario NunesHNHilario Nunes
- Nadera J. SweissNSNadera J. Sweiss
- Elyse E. LowerELElyse E. Lower
- 8 February 2013
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 41 (6) , 1424-1438
Abstract
The treatment options for pulmonary sarcoidosis have increased over the past 10 years. As new treatments have been introduced, the best way to assess and compare treatments remains unknown. The goal of this review is to discuss the standard treatments for pulmonary sarcoidosis, including glucocorticoids, and cytotoxic agents, such as methotrexate, azathioprine and leflunomide, and compare them to the newer biological agents, such as infliximab and adalimumab. We also discuss some novel treatments which are currently being evaluated. To compare these different regimens, we look at the measures used to assess response. These include pulmonary function, chest imaging, steroid sparing potential and, more recently, improvements in quality of life measures. While there is, as yet, no standard assessment for response, there is a growing consensus that response to treatment may include improvement of one or more of the following: forced vital capacity, chest imaging and steroid sparing. Several drugs used for pulmonary sarcoidosis have demonstrated improvement in one or more of these measures.Keywords
This publication has 124 references indexed in Scilit:
- Efficacy and Safety of Apremilast in Chronic Cutaneous SarcoidosisArchives of Dermatology, 2012
- Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infectionArthritis Care & Research, 2007
- Role of Liver Function Tests in Detecting Methotrexate-Induced Liver Damage in SarcoidosisArchives of internal medicine (1960), 2003
- Leflunomide for the treatment of rheumatoid arthritisCochrane Database of Systematic Reviews, 2002
- Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Corticosteroid Therapy in Pulmonary SarcoidosisJAMA, 2002
- Clinical, laboratory, radiographic, and histopathologic features of methotrexate‐associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature reviewArthritis & Rheumatism, 1997
- Prolonged Use of Methotrexate for SarcoidosisArchives of internal medicine (1960), 1995
- Methotrexate for Rheumatoid ArthritisArthritis & Rheumatism, 1994
- Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosisLung, 1987